Stock Events

Stock Events

Cullinan Therapeutics (CGEM) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.07

-0.96

-0.85

-0.74

Details

Expected EPS

-0.835881

Actual EPS

-0.75

Surprise EPS

0.09

Surprise Percent

+10.27%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.75 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.